CNE100001M79
CNE100001M79
FOSUN PHARMA
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 41.661.612.748 | 41.067.195.863 | 1.4% |
| Cost of Revenue | 20.800.103.192 | 21.365.573.972 | 2.6% |
| Gross Profit | 20.861.509.556 | 19.701.621.890 | 5.9% |
| 17.715.355.560 | 16.498.479.846 | 7.4% | |
| Operating Income | 3.146.153.996 | 3.203.142.045 | 1.8% |
| Pretax Income | 5.111.983.264 | 4.169.281.680 | 22.6% |
| Net Income Common Stockholders | 3.370.561.563 | 2.769.886.631 | 21.7% |
| -- | -- | -- | |
| -- | -- | -- |